In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride Drug Master File in Korea (N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride. The MFDS reviews the N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride KDMF as part of the drug registration process and uses the information provided in the N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of N-cinnamyl-N-methyl-1-naphthalenemethylamine hydrochloride suppliers with KDMF on PharmaCompass.